跳至主要内容
临床试验/EUCTR2010-020098-18-FR
EUCTR2010-020098-18-FR进行中(未招募)不适用

CrYSTobs A cohort of patients with cystinosis : compliance to cysteamine and neurological complicationsAn auxiliary study to Raptor RP103 03 and RP103 04 - CrYSTobs

HOSPICES CIVILS DE LYO0 个研究点开始时间: 2010年7月12日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with nephropathic cystinosis
  • - Male and female subjects with confirmed diagnosis of nephropathic cystinosis (defined by clinical signs and WBC cystine level).
  • - Age > 6 years.
  • - Subjects receiving any oral cysteamine treatment: Cystagon? or RP103.
  • - Subjects must be able to swallow their typically administered cysteamine treatment.
  • - Sexually active female subjects of childbearing potential must agree to utilize the same acceptable form of contraception from day 1 through completion of the study.
  • - Subjects or their parent or legal guardian must provide written informed consent prior to participation in the study.
  • - Subjects covered by or having the right to social security.
  • - Age and sex matched to study population :
  • Age range : patients aged 6 to 11 years , patients aged 12 to 17 years, adult patients: 18 or above.
  • Sex : male or female
  • - Subjects or their parent or legal guardian must provide written informed consent prior to participation in the study.
  • - Subjects covered by or having the right to social security.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients with nephropathic cystinosis
  • - Subjects receiving any form of cysteamine medication through a gastric tube.
  • - Subjects with known hypersensitivity to cysteamine and penicillamine.
  • - Females who are nursing, planning a pregnancy, known or suspected to be pregnant, or with a positive urinary pregnancy test.
  • - Subjects who, in the opinion of the Investigator, are not able or willing to comply with the protocol.
  • Contra-indication to MRI assessment
  • Controls for metabonomic assessment
  • - Any uropathology or nephropathology.

研究者

发起方
HOSPICES CIVILS DE LYO

相似试验